Use Delcath to protect against small markets fluctuations. The stock experiences very speculative upward sentiment.
1 Month Beta ..........
4.16
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Delcath will likely underperform.
Krishna Kandarpa Executive Vice President - Research & Development, Chief Medical Officer, Ph.D
John Purpura Executive Vice President - Regulatory Affairs and Quality Assurance
Delcath Price and Market Media
The median price of Delcath for the period between Wed, Apr 25, 2012 and Fri, May 25, 2012 is 2.51 with a coefficient of variation of 11.18. The daily time series for the period is distributed with a sample standard deviation of 0.28, arithmetic mean of 2.48, and mean deviation of 0.23. The Stock received some media coverage during the period.
Delcath Systems Inc. [DCTH] is traded on American Stock Exchange in USA. It is located in Delcath Systems, Inc.New York, NY and employs 80 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 74.64 M. Delcath Systems Inc. conducts business under Healthcare sector and is part of Drug Delivery industry. This company has 49.76 M outstanding shares of which 8.34 M shares are currently shorted by private and institutional investors with about 22.9 trading days to cover.
Delcath Liquidity
The company has Current Ratio of 2.54 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
AMEX
